Zdrowie i gospodarka · 30/09/2021

FDA Releases Draft Guidance for Industry on Studying Multiple Versions of Cellular or Gene Therapy Products in Early-Phase Clinical Trials

The FDA has published a draft guidance document outlining recommendations for sponsors interested in conducting early-phase clinical trials with multiple versions of cellular or gene therapy products for a single disease, with the goal of gathering preliminary evidence of safety and activity in a single clinical trial.